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ABSTRACT 
Cadmium (Cd) was recently identified as a risk factor for osteoporosis. Skeletal damage may be the 
critical effect of low-level long-term exposure to Cd in the general population exposed via food, but 
the mechanisms behind this are not clearly understood.  
We investigated the effect of dietary Cd exposure on metals involved in bone turnover. Female rats 
received a Cd-supplemented diet (0, 10, 50, or 200 CdCl2 mg/kg diet) for 13 weeks. Cd and essential 
metals stored in the liver were measured by ICP-MS multianalysis. Mineral content of the livers was 
modified according to Cd level: iron, magnesium and selenium decreased while copper, zinc and 
manganese increased with increasing Cd levels. Iron was the most strikingly affected metal, falling to 
one-fifth of control values at high dietary Cd exposure. In this dosage group, selenium decreased to 
36% of mean control concentrations while zinc increased to 168%. This mineral imbalance, especially 
depleted iron stores, can contribute, at least in part, to the Cd-associated risk of osteoporosis.  
The association between iron metabolism and Cd exposure should be investigated in humans, as Cd 
and low iron stores could act synergistically as risk factors for osteoporosis.  
 
 
 
 
 
 
 
 
 3 
 
INTRODUCTION 
 
The heavy metal and environmental pollutant cadmium (Cd) has recently been identified as a risk 
factor for osteoporosis (Staessen et al, 1999). Cd accumulates in humans, mainly in the kidneys, via 
the food chain. The more Cd contaminates the agricultural environment the more it contaminates the 
food chain and endangers human health, and its levels in soils have increased continuously during the 
last century. The diet is the main source of Cd intake in non-smoking non-professionally exposed 
people. In France, the Cd concentration in human bones rose tenfold during the 20th century (Staessen 
et al, 1999). Today, daily Cd intake is estimated to be 10-30 µg in Europe in unpolluted areas 
(Nasreddine and Parent-Massin, 2002) and 4-27 µg in France  (Noël et al, 2003). This represents 6-
50% of the Provisional Tolerable Weekly Intake (PTWI) set by the Joint Expert Committee on Food 
Additives (JECFA) of the World Health Organization, equivalent to 1 µg/kg/d  (WHO, 1989). 
Exposure to Cd is associated with renal and skeletal damage and also some cancers. Renal 
tubular damage is considered to be the critical health effect of Cd exposure, both in the general 
population and in occupationally exposed workers. Risk assessment is based on epidemiological data 
from populations exposed to high levels of Cd, using dose-response calculations assuming that critical 
biological endpoints are similar to those in populations with very low exposure. However, the effects 
of very low levels of ingested Cd are not well known. Skeletal damage (osteoporosis) may be a critical 
effect of Cd exposure, as shown in humans and in animal studies. Bone changes induced by cadmium 
were first described in long-term high-level exposure to cadmium, and were considered to be 
secondary to kidney disease (Itaï Itaï disease) (Jarüp et al., 1998). But primary decrease in bone 
mineralisation has recently been associated with low cadmium exposure in occupationally, in 
environmentally exposed people (Staessen et al, 1999; Alfven et al., 2002), and induced 
experimentally at low doses in rats (Ohta et al., 2000). 
Osteoporosis, a major public health problem, mainly affects aging people (senile osteoporosis) 
and postmenopausal women, especially in elderly Caucasian women (Berglund et al., 2000). This 
population group also shows mineral deficiencies, notably in iron. The mechanisms behind cadmium-
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induced bone damage are not clear, one possible mechanism implicates Cd interaction with calcium 
metabolism (Wu et al., 2001), with calciuria and/or dysfunction of tubular cells leading to decreased 
Ca absorption from the gut. But both experimental and epidemiological data indicate that cadmium 
can affect bone mineralisation as primary effect, well before the onset of kidney damage. (Ohta et al., 
2000; Ogoshi et al., 1989; Wilson and Bhattacharyya, 1997). 
Cadmium also interferes with trace metals acting in bone mineralisation, mainly zinc, iron, 
and copper. Previously described interactions involved various mineral-deficient diets in animals: for 
instance in both zinc and iron deficiencies, Cd uptake by tissues increased (Ohta and Cherian, 1995). 
The effects of essential minerals on Cd accumulation and toxicity have been investigated in vivo by 
feeding Cd-containing diets supplemented with various minerals: the most protective effect against 
cadmium accumulation was observed with a supplement combining calcium, phosphorus, iron and 
zinc (Groten et al., 1991). All these essential minerals interacting with cadmium play a role in bone 
turnover. Chronic exposure to environmental Cd may disturb essential mineral metabolism at low 
doses. Besides interfering with calcium, the effect of Cd on trace metal metabolism might help to 
explain the Cd-associated risk of osteoporosis. The present study was designed to answer the question: 
does repeated low-level Cd exposure modify mineral metabolism, before nephropathy occurs and 
which metal is the most affected in correlation with Cd accumulation? In female rats, we investigated 
the hepatic storage of essential minerals and the correlation with Cd accumulation after 13-weeks 
dietary exposure, that is to say the same mode of exposure as the general population.  
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MATERIALS AND METHODS 
 
Animals, treatment and sampling 
Three-week-old female Wistar rats (Iffa Credo, France) were housed 5/cage under standard conditions 
with a 12 h light/dark cycle. They were fed a standard pellet diet meeting the requirements of growing 
rats, composed of 26% maize, 36% wheat bran, 12% fish flour, 10% meat flour, 5% dried yeast, 5% 
soya, 3% alfalfa, 3% vitamin and mineral mix which was prepared by UPAE (Unité de Préparation des 
Aliments Expérimentaux, INRA Jouy-en-Josas, France), according to recommendations of INRA 
(Potier de Courcy et al., 1989). The diet was composed of 48% carbohydrate, 25% protein, 4% fat, 
0.6% calcium, 0.5% phosphorus. After a 10-day adaptation period, the control rats (15) continued to 
be fed the baseline diet while four treatment groups received a CdCl2-supplemented diet. The four 
treatment groups (10 rats each) received the supplemented CdCl2 diet as follows:10 mg CdCl2/kg diet 
(low dosage group), 50 mg CdCl2/kg diet (medium dosage group) 200 mg CdCl2/kg diet (high dosage 
group) and 200 mg CdCl2/kg diet + N-acetylcysteine (NAC) by gavage (gavage group: 100 mg/kg, 5 
days per week). NAC is considered a protective agent against Cd toxicity. Five rats used as positive 
controls for renal pathology received daily a 1 mg/kg CdCl2 injection subcutaneously for eight weeks 
(Lermioglu and Bernard, 1998; Liu et al., 1998) and were then sacrificed. All animals were examined 
daily for clinical signs, and the ovarian cycle was checked in treatment groups by vaginal smear from 
the 13th week of age. Rats were weighed weekly and their food and water consumption was measured. 
At weeks one, four, eight, and thirteen, blood samples were collected at the retro-orbital plexus into 
special heparinized vacutainer tubes, guaranteed free of any trace of metals, to measure cadmium 
concentrations. In treatment groups, total volume of urine was collected and measured over a 24-hour 
period by maintaining animals individually in metabolism cages, at weeks four, eight, eleven and 
thirteen. After 13 weeks of dosing, the rats were fasted for at least 4 hours, then anesthetized for blood 
collection before sacrifice. 
At necropsy, liver, kidneys, uterus and ovaries were removed and weighed. These organs and right 
kidneys were preserved in 10% formaldehyde for microscopic observations while left kidneys and 
livers were preserved at –20°C before analysis. Hematoxylin and eosin-stained sections from right 
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kidneys and uterus were examined histopathologically, under light microscopy, to look for any 
pathological changes between control and treated rats. Renal tubular epithelium changes in cortex and 
medullary were specially sought. 
 
Analytical procedures 
Cd concentrations in blood and kidneys were measured by graphite furnace atomic absorption 
spectrophotometry (AAS) with a Perkin-Elmer Zeeman 4100 spectrophotometer (PE 4100 ZL), 
according to the techniques described previously (Houpert et al., 1997). 
In the diet and livers of treated and control rats, we analysed the mineral content by ICP-MS after 
microwave digestion, as previously described (Noël et al., 2003), excepted for iron which was analised 
by AAS. 
In the 24 h urine samples, we measured urinary pH, gammaglutamyltransferase (GGT) and alkaline 
phosphatase (ALP) by colorimetry (Enzyline GGT and Enzyline ALP optimisé, Biomérieux, 69280 
Marcy l’Etoile, France). Tubular type proteinuria was assessed by measuring the urinary excretion of 
Clara cell protein (CCl6), a low-molecular-weight protein very sensitive to proximal injury (Bernard 
and Lauwerys, 1995). We investigated the urinary concentration of Clara cell proteins using a 1.5 ml 
urine sample from the high dosage treatment group and control groups in collaboration with Professor 
Bernard’s Laboratory (Halatek et al., 1998). 
 
Statistical analysis 
Statistical analyses were conducted by analysis of variance (ANOVA using the general linear models 
procedure of the SAS system, Cary, NC). The 4 dosage groups were compared on the same treatment 
weeks using the Student-Newman-Keuls test following ANOVA for GGT, PAL, and urinary pH. 
Pearson’s correlation coefficients between mineral hepatic storage and Cd concentrations were 
calculated using the SAS “CORR” procedure. Comparisons were considered significant at p= 0.05. 
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RESULTS 
 
Diet composition and food consumption  
Mineral composition was verified in all diets by ICP-MS (Table 1), and was within the target for Cd 
concentrations, and iron, zinc, and calcium were within normal ranges. Total food intake and body 
weights changed similarly in all the treatment groups during the 13 weeks of treatment, except for a 
lower weight gain from the fifth week of treatment in the high dosage group (Fig.1). In the latter, the 
decrease of the mean body weight on the 5th week of exposure exceeded 10% of controls weights (–
13.65% compared to controls). Based on food intake, the mean daily intake of Cd during the treatment 
period was 0.36 mg/kg of body weight/day (mg/kg/d) in the low dosage group, 2.8 mg/kg/d in the 
medium, and 12.4 mg/kg/d in the high dosage group. The dietary treated rats showed no treatment-
related clinical signs or biological modifications and had normal sexual cycles during the last five 
weeks of exposure. Food intake of positive control rats treated by injection of CdCl2 was lower than 
that of other groups during the last three weeks (6,7,8) of treatment (Fig.1). 
 
Pathology and urine analysis 
In treated rats, there were no statistically significant between-group differences in body weight after 
13 weeks, nor were there any significant differences in the weights of liver (range 8.76-9.10 g) or 
kidney (range 0.81-0.97 g). No treatment-related tubular lesions were noted in these animals, while in 
the positive controls group macroscopic and microscopic kidney lesions were detected. After 8 weeks 
injection of CdCl2, the kidneys appeared pale compared to normal ones. Histologically, renal toxicity 
was characterized by necrosis of tubular epithelia, with tubular dilatation and calcinosis. A 3.5-fold 
increase in CC16 protein excretion at the end of the 8 weeks treatment in the injected rats confirmed 
renal dysfunction while the mean level in the high dosage group was not significantly higher 
compared to controls. 
 
Blood cadmium kinetics (Fig. 2) 
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Control blood Cd concentrations were below the limit of quantification of the analytical technique (0.8 
µg/L). In the injected-group, Cd concentrations increased from 480 ± 58 µg/L after 4 weeks of 
administration to 821 ± 111 µg/L after 8 weeks. The mean blood concentration-time profile of 
cadmium during dietary administration is shown in Figure 2. Blood Cd concentrations increased to 41 
± 10 µg/L and 137 ± 26 µg/L on the 8th week of exposure in the medium and high dosage groups, 
respectively, before decreasing on the 13th week in all the treatment groups. In the NAC-treated group, 
blood concentrations paralleled those observed in the high dosage group, and showed a 15% decrease 
(without statistical significance). In the low dosage group, blood cadmium showed a maximum level 
one week after starting dietary exposure (4.2 ±1.6 µg/L) and decreased thereafter. 
 
Cadmium in liver and kidney; minerals in the liver (Figs. 3, 4) 
Cadmium concentrations in whole kidney were correlated with diet concentration in orally-treated 
rats, ranging from 1.7 ± 0.3 mg/kg wet weight (ww) to 42 ± 7 mg/kg ww in the low and high dosage 
groups respectively (Fig. 3). In the Cd-injected group, they reached 99 ± 11 mg/kg ww. Cadmium 
concentrations in the liver, measured by ICP-MS, ranged from 0.86 ± 0.27 to 37 ± 4 mg/kg wet weight 
in dietary treated rats, representing 83% to 115% of kidney concentrations. Cadmium levels in kidney 
and liver were both decreased by about 8% (not statistically significant) in NAC-treated rats compared 
to the high treatment group without NAC. Mineral content in the liver was modified in correlation to 
cadmium content, both positively and negatively: iron, magnesium, selenium, and sodium were 
decreased in correlation with Cd concentrations, while copper, zinc, manganese and molybdenum 
increased when Cd increased (Fig. 4). The most highly correlated minerals were iron (r = - 0.79, 
p<0.001), zinc (r =0.88, p<0.001), and selenium (r = -0.77, p<0.001). The most strikingly affected 
mineral was iron, which decreased to one-fifth the value of controls at high dosage, and to 40% of 
controls at medium dosage. Selenium decreased to 36% of mean control concentrations in the high 
dosage group while zinc increased up to 168% of control values. There were no significant variations 
in the hepatic storage of minerals in the high dosage group receiving NAC compared to the high 
dosage group without NAC. 
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DISCUSSION 
 
The present results suggest that cadmium can be a risk factor for the development of osteoporosis at 
low doses by altering mineral metabolism before the occurrence of kidney lesions. In this study, we 
demonstrate that increasing dietary Cd exposure increased the related variations in the hepatic storage 
of various essential trace elements, in a dose-dependant manner, but did not induce nephrotoxicity. 
The liver is a critical organ in the homeostasis of essential metals including calcium, copper, iron and 
zinc. Interactions between essential minerals and Cd exposure have been reported in vivo in various 
animal species and in vitro (Blais et al., 1999), mainly involving calcium and zinc but also copper, 
iron, selenium. Most studies evaluated the effects of nutritional status on Cd retention using different 
depleted or supplemented diets (Groten et al., 1991; Houpert et al., 1997; Ohta and Cherian, 1995; 
2001; Reeves and Cheney, 2000). Our study is, to our knowledge, the first to show a clear dose-
dependant effect of dietary Cd on mineral metabolism, using multianalysis measurement of minerals 
in an in vivo study. We exposed young female rats subchronically to a cadmium-supplemented diet, in 
order to reproduce dietary exposure, the main source of environmental exposure to Cd in the general 
population. As often reported, blood cadmium reached a concentration corresponding to the intensity 
of the exposure after some weeks in rats, whereas this takes some months in humans (Jarüp et al., 
1998). In our study, blood cadmium levels in low dosage dietary-treated rats corresponded to the 
upper levels reported in smokers (1 to 4 µg/L), and were higher than those induced in the rat by long-
term exposure to polluted rice (Oishi et al., 2001). No treatment-related clinical signs or kidney lesions 
were observed at the end of the 13-week exposure in any of our treatment groups. ICP-MS analysis of 
livers revealed decreased concentrations of iron, magnesium and selenium together with increased 
copper, zinc, and manganese that were correlated with total Cd intake. Similar changes have already 
been reported: decreased iron levels and increased zinc and copper in rat livers after long-term oral 
exposure at non-toxic dosage (Oishi et al., 2001), and induced iron-deficiency state in growing rats at 
toxic dosage (Crowe and Morgan, 1997). We used kidney Cd levels to estimate the absorbed Cd dose 
and Cd accumulation in liver and kidney. Cd accumulation was in accordance with that previously 
described after dietary exposure in the rat (Groten et al., 1991) and reflected total Cd intake. Kidney 
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cadmium concentrations reflect total Cd intake better at low oral doses, both in the rat and in humans 
(Ohta et al, 2000; Torra et al., 1995). In our study, the low dosage group showed liver concentrations 
that were one-half those of kidney, while in the higher dosage groups, liver concentrations represented 
on average 85% of kidney concentrations. These low group liver concentrations in rats correspond to 
those reported in non-professionally exposed humans (0.98 ±0.5 µg/g : Torra et al., 1995), which were 
highly correlated with liver zinc, as in our present results in rats. Cadmium kidney concentrations are 
generally associated with tubular nephropathy. In the present study, kidney lesions were observed only 
in the positive control rats which showed nearly 100 mg/kg whole kidney cadmium concentrations 
after 8 weeks: this agrees with numerous previous reports concerning high cadmium exposure, and is 
consistent with critical renal concentrations of about 100 µg/g tissue in the rat (Mitsumori et al., 98, 
Groten et al., 1994; Liu et al, 1998). In the present study, dietary treated rats with kidney Cd 
concentrations below 50 mg/kg did not develop tubulopathy.  
The general effect of Cd on mineral metabolism at low dose can help to explain the cadmium-
associated risk of osteoporosis in humans. Development of osteoporosis is mainly dependant on 
calcium metabolism, but also upon other nutrients (Illich and Kerstetter, 2000). Our study 
demonstrates a dose-dependent effect on storage of essential trace elements, which could contribute to 
the osteoporotic changes caused by Cd, in addition to the well-known inhibition of Ca absorption. 
Most animal studies report effects of Cd exposure on bone, together with bone accumulation of Cd. In 
rats, prolonged oral exposure to Cd caused bone lesions including decreased mineral density (Berglund 
et al, 2000; Brzoska and Monuszko-Jakoniuk, 2001) osteomalacian changes (Brzoska and Monuszko-
Jakoniuk, 2001), and decreased mechanical strength correlated with Cd in bones (Ogoshi et al., 1989). 
The bone demineralisation developing at low-dose prolonged oral exposure in animal studies was 
independent of renal damage and was observed before renal dysfunction (Ohta et al., 2000).The Cd-
induced changes in hepatic storage of essential minerals before renal damage occurs must induce 
changes in homeostasis of minerals, to which bone tissue is very sensitive. A Cd-induced decrease in 
essential minerals in bone tissue has been reported in several studies: Cd mainly affected Ca bone 
content, but also Zn and iron (Brzoska and Monuszko-Jakoniuk, 2001; Ogoshi et al., 1989). Bone 
demineralisation can result indirectly from disturbed mineral homeostasis, or directly due to the in situ 
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action of cadmium on bone, or by both mechanisms. Cadmium accumulated in bone could affect 
activity of bone cells and enhance bone mineral loss directly (Bhattacharyya et al. 1988; Wilson et al., 
1996). But metal imbalance is most likely the consequence of an indirect effect rather than an in situ 
effect, since some authors failed to show cadmium accumulation when metal balance in bone was 
disrupted by low-dose chronic Cd exposure (Oishi et al., 2001). Also, zinc co-administration 
prevented bone lesions without preventing Cd accumulation in bone (Brzoska and Monuszko-
Jakoniuk, 2001). 
Here, we suggest that Cd is a factor of osteoporosis because it alters the metabolism of several 
essential metals involved in mineralisation, in addition to its effect on calcium metabolism. Each of 
the minerals affected by Cd exposure have a role in bone formation, and their simultaneous Cd-
induced changes can damage bone. Essential metals are necessary for optimal formation of bone 
matrix and its mineralisation. They act as cofactors for specific enzymes. The most strikingly 
decreased metal, iron, contributes to collagen maturation, serves as a cofactor for prolyl and lysyl 
hydroxylases, which catalyze an ascorbate-dependant hydroxylation. In rats, an iron-deficient diet 
induced reductions in bone density as does calcium restriction, and calcium restriction combined with 
iron deficiency results in an additive decrease in femur bone mineral density and bone strength 
(Medeiros et al., 2002). In adolescent girls, a recent four-year clinical trial of calcium supplementation 
showed a trend for a positive association between BMD (bone mineral density) of forearm and ferritin 
at baseline (Illich and Kerstetter, 2000). Zinc, copper, and magnesium imbalances can also be 
implicated in Cd-induced osteoporosis because of their implication in bone mineralisation and bone 
modeling/remodelling (Brzoska and Monuszko-Jakoniuk, 2001; Ogoshi et al., 1989; Klevay, 1998, 
Medeiros et al., 1997; Rude et al., 1999). 
Iron deficiency (ID) and osteoporosis are two major health problems worldwide, so that 
public-health implications of cadmium exposure may be important. Risk assessment is based on renal 
tubular damage, which has been considered the critical health effect of cadmium exposure, both in the 
general population and in occupationally exposed workers. However, osteoporosis may be a critical 
effect after dietary cadmium exposure. The role of low-level cadmium exposure in increased risk of 
osteoporosis, first suggested by the correlation between decreased bone density and urinary cadmium 
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in postmenopausal women (Staessen et al., 1999), was confirmed in environmentally or 
occupationally exposed men and women (Alfven et al, 2002). Cadmium exposure in humans has been 
associated with changes in bone mineral content similar to those found in animals: negative correlation 
with calcium and magnesium, decreased calcium/zinc ratio related to the degree of osteomalacia in 
ribs (Honda et al., 1997), and positive correlation between zinc liver and Cd liver. Recent results from 
long-term animal studies show that renal toxicity is not induced by oral administration of low amounts 
of cadmium, in contrast to high-dose treatment, although tissue accumulation occurs (Shibutani et al., 
2001). Risk assessment by the 33rd Joint FAO/WHO Expert Committee on Food Additives is based on 
dose/response calculations for renal toxicity, assuming that Cd-induced renal toxicity can occur below 
a critical level in the kidney. However, oral exposure to very low levels of cadmium for a lifetime 
could induce subtle metabolic changes pertinent for risk assessment. From the point of view of a re-
evaluation of the critical effects of cadmium exposure, iron deficiency would seem a very sensitive 
indicator. The association between iron metabolism and Cd exposure needs investigation in humans, 
as further studies are necessary to clarify the association between osteoporosis and serum ferritin, 
particularly in patients who are iron deficient. Iron status itself influences absorption of cadmium so 
that Cd and low iron stores could act together as risk factors for osteoporosis. In conclusion, our 
findings show a dose-dependent mineral imbalance occurring before nephropathy. At low-dose 
exposure, impaired metal homeostasis may be a more sensitive indicator than renal cortical cadmium 
accumulation, and could thus contribute to explaining the increased risk of osteoporosis due to Cd 
exposure. 
 13 
 
Ackowledgements 
This work was supported by the French Ministry of Agriculture and Fisheries (DGER) for UMR N° 
95025104, and by Grant INSERM N° EN98-21 from the French Ministry of Environment. 
We thank Prof. F. Crespeau (Alfort Veterinary School, Pathology, Maisons-Alfort, France), and Prof. 
A. Bernard (Unit of Industrial Toxicology and Occupational Medicine, Louvain-La-Neuve, Belgium) 
for their contribution to this work. The excellent technical assistance of A. Duché and D. Huet 
(Toxicology unit, Alfort Veterinary School, Maisons-Alfort, France) is gratefully acknowledged. 
 14 
REFERENCES 
Alfven T., Jarüp L., Elinder C.G., 2002. Cadmium and lead in blood in relation to low bone mineral 
density and tubular proteinuria. Environmental Health Perspectives 110, 699-702. 
Berglund M., Akesson A., Bjellerup P., Vahter M., 2000. Metal and bone interactions, Toxicology 
Letters 112-113, 219-225. 
Bernard A., Lauwerys R.., 1995. Low-molecular-weight proteins as markers of organ toxicity with 
special reference to Clara cell protein. Toxicology Letters 77, 145-151. 
Bhattacharyya M.H., Whelton B.D., Stern P.H., Peterson D.P., 1988. Cadmium accelerates bone loss 
in ovariectomized mice and fetal limb bones in culture. Proceedings of the National Academy of 
Sciences of USA 85, 8761-5. 
Blais A., Lecoeur S., Milhaud G., Tomé D., Kolf-Clauw M., 1999. Cadmium uptake and 
transepithelial transport in control and long-term exposed caco-2 cells: the role of metallothionein. 
Toxicology and Applied Pharmacology 160, 76-85. 
Brzoska MM, Monuszko-Jakoniuk J., 2001. Interactions between cadmium and zinc in the organism. 
Food and Chemical Toxicology 39, 967-980. 
Crowe A., Morgan E.H., 1997. Effects of dietary cadmium on iron metabolism in growing rats. 
Toxicology and Applied Pharmacology 145, 136-146. 
Groten J.P., Koeman J.H., van Nasselrooij J.H.J., Luten J.B., Fentener van Vlissingen, J.M., Stenhuis 
W.S., van Bladeren P.J., 1994. Comparison of renal toxicity after long-term oral administration of 
cadmium chloride and cadmium-metallothionein in rats. Fundamental and Applied Toxicology 23, 
544-552. 
Groten J.P., Sinkeldam E.J., Muys T., Luten J.B., Van Bladeren P.J., 1991. Interaction of dietary Ca, 
P, Mg, Cu, Fe, Zn and Se with the accumulation and oral toxicity of cadmium in rats. Food and 
Chemical. Toxicology 29, 249-258. 
Halatek T., Hermans C., Broeckaert F., Wattiez R., Wiedig M., Toubeau G., Falmagne P., Bernard A., 
1998. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive 
immunoassay. European Respiratory Journal 11, 726-733. 
 15 
Honda R., Tsuritani I., Ishizaki M., Yamada Y., 1997. Zinc and copper levels in ribs of cadmium-
exposed persons with special reference to osteomalacia. Environmental Research 75, 41-48. 
Hotz P., Buchet J.P., Bernard A., Lison D., Lauwerys R., 1999. Renal effects of low-level 
environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. 
Lancet 30, 1508-1513. 
Houpert P., Mehennaoui S., Federspiel B., Kolf-Clauw M., Joseph-Enriquez B., Milhaud G., 1997. 
Transfer of cadmium from feed to ewe food products: variations in transfer induced by lead and 
zinc. Environmental Sciences 5, 127-138. 
Illich J.Z, Kerstetter J.E., 2000. Nutrition in bone health revisited: a story beyond calcium. Journal of 
the American College of Nutrition 19, 715-737. 
Jarüp L, Berglund M., Elinder C.G., Nordberg G., Vahter M., 1998. Health effects of cadmium 
exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 24, 1-52. 
Klevay L.M., 1998. Lack of a recommended dietary allowance for copper may be hazardous to your 
health. Journal of the American College of Nutrition 17, 322-326. 
Lermioglu and Bernard A., 1998. Effect of calmodulin-inhibitors and verapamil on the nephrotoxicity 
of cadmium in rat. Toxicology letters 95, 9-13 
Liu J., Habeebu S.S., Liu Y., Klaassen C.D., 1998. Acute CdMT injection is not a good model to study 
chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT 
injection in rats. Toxicology and Applied. Pharmacology 153, 48-58. 
Medeiros D., Ilich J., Ireton J., Matkovic V., Shiry L., Wildman R., 1997. Femurs from rats fed diets 
deficient in copper or iron have decreased mechanical strength and altered mineral composition. 
Journal of Trace Element and Experimental Medicine 10, 197-203. 
Medeiros D.M., Plattner A., Jennings D., Stoecker B., 2002. Bone Morphology, strength and density 
are compromised in iron-deficient rats and exacerbated by calcium restriction. The Journal of 
Nutrition 132, 3135-3141. 
Mitsumori K., Shibutani M., Satoh S., Onodera H., Nakagawa J., Hayashi Y, Ando M., 1998. 
Relationship between the development of hepatorenal toxicity and cadmium accumulation in rats 
 16 
given minimum to large amounts of cadmium chloride in the long term : preliminary study. 
Archives of Toxicology 75, 545-552. 
Nasreddine L., Parent-Massin D., 2002. Food contamination by metals and pesticides in the European 
Union. Should we worry? Toxicology Letters 127, 29-41.  
Noël L., Leblanc J-C., Guérin T., 2003. Determination of several elements in duplicate meals from 
catering establishments using closed vessel microwave digestion with inductively coupled plasma 
mass spectrometry detection: estimation of daily dietary intake. Food Additives and Contaminants 
20, 44-56. 
Ogoshi K., Moriyama T., Nanzai Y., 1989. Decrease in the mechanical strength of bones of rats 
administered cadmium. Archives of Toxicology 63, 320-324. 
Ohta H., Cherian M.G., 1995. The influence of nutritional deficiencies on gastrointestinal uptake of 
cadmium and cadmium-metallothionein in rats. Toxicology 31, 71-80. 
Ohta H., Yamauchi Y., Nakakita M., Tanaka H., Asami S., Seki Y., Yoshikawa H., 2000. Relationship 
between renal dysfunction and bone metabolism disorder in male rats after long-term oral 
quantitative cadmium administration. Industrial Health 38, 339-55. 
Oishi S., Nakagawa J-I, Ando M., 2001. Effects of ingestion of cadmium-polluted rice or low-dose 
cadmium-supplemented diet on the endogenous metal balance in female rats. Biological Trace 
Element Research 84, 155-167. 
Potier de Courcy G., Durand G., Abraham J., Gueguen L., 1989. Recommendations on the feeding 
conditions of the laboratory animals (rats and mice). Sciences des aliments 9, 209-217. 
Reeves PG, Chaney RL., 2002. Nutritional status affects the absorption and whole-body and organ 
retention of cadmium in rats fed rice-based diets. Environmental Science & Technology 36, 2684-
2692. 
Rude R.K., Kirchen M.E., Gruber H.E., Meyer M.H., 1999. Magnesium deficiency-induced osteoporosis 
in the rat: uncoupling of bone formation and bone resorption. Magnesium Research 12, 257-67. 
Shibutani M., Mitsumori K., Satoh S-I.,Hiratsuka H., Satoh M., Sumiyoshi M., NishijimaM., Katsuki Y., 
Suzuki J., Nakagawa J-I., Akagi T., Imazawa T., Ando M., 2001. Relationship between toxicity and 
 17 
cadmium accumulation in rats given low amounts of cadmium chloride or cadmium-polluted rice for 
22 months. The Journal of Toxicological Sciences 26, 337-58. 
Staessen J.A., Roels H.A., Emelianov D., Kuznetsova T., Thijs L., Vangronsveld J., Fagard R., 1999. 
Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective 
population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. 
Lancet 353, 1140-4. 
Torra M, To-Figueras J, Rodamilans M, Brunet M, Corbella J., 1995. Cadmium and zinc relationship in 
the liver and kidney of humans exposed to environmental cadmium. Science of the Total Environment 
170, 53-57. 
WHO; 1989.Toxicological Evaluation of certain food additives and contaminants, Cambridge University 
Press. Food Additives Series 24. World Health Organization, Geneva. 
Wilson A.K and Bhattacharyya M.H., 1997. Effects of cadmium on bone: an in vivo model for the early 
response. Toxicology and Applied Pharmacology 140, 451-460. 
Wilson A.K., Cerny E.A., Smith B.D., Wagh A., Bhattacharyya M.H., 1996. Effects of cadmium on 
osteoclast formation and activity in vitro. Toxicology and Applied Pharmacology 140, 451-460. 
Wu X., Jin T., Wang Z., Ye T., Kong Q., Nordberg G., 2001. Urinary calcium as a biomarker of renal 
dysfunction in a general population exposed to cadmium. Journal of Occupational and Environmental 
Medicine 43, 898-904. 
 18 
TABLE AND FIGURE LEGENDS 
 
Table 1 Metal analyses of diets: basal diet (control rats) and CdCl2-supplemented diet (low dosage: 
10 mg CdCl2/kg diet ; middle dosage : 50 mg CdCl2/kg diet; high dosage: 200 mg CdCl2/kg diet). 
 
Figure 1 Food consumption (1a) and body weights (1b) during Cd exposure in female rats 
 
Figure 2 Blood cadmium concentration during the 13-weeks dietary exposure to cadmium in female 
rats 
 
Figure 3 Cadmium levels in whole kidneys and livers of rats treated orally for13-weeks with CdCl2-
supplemented diets (mg/kg wet weight) 
 
Figure 4 Changes in mineral contents in the livers of rats after 13-weeks dietary cadmium exposure 
(expressed as % of controls fed baseline diets). Treatment groups received 10, 50, or 200 mg CdCl2/ 
kg diet. 
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Table 1 Metal analyses of diets: basal diet (control rats) and CdCl2-supplemented diet (low dosage: 
10 mg CdCl2/kg diet ; middle dosage : 50 mg CdCl2/kg diet; high dosage: 200 mg CdCl2/kg diet). 
 
 
 Basal and cadmium supplemented diets 
Metals Basal diet Low dosage diet   
Middle dosage diet 
 
High dosage diet 
 
Cr (mg/kg) 2.24  0.12 2.25  0.19 2.31  0.20 2.49  0.25 
Mn (mg/kg) 61.5  1.3 66.6  1.6 65.2  1.5 69.4  2.1 
Fe (mg/kg) 28.4  1.2 30.6  2.1 29.8  1.7 37.1  2.3 
Co (mg/kg) 10.7  0.5 12.3  0.4 12.8  0.4 13.6  0.6 
Ni (mg/kg) 1.35  0.10 1.32  0.15 1.28  0.12 1.40  0.12 
Zn (mg/kg) 72.1  2.9 81.0  2.2 82.7  2.0 76.7  2.6 
Cu (mg/kg) 10.3  0.4 16.9  0.9 9.7  1.1 10.5  0.9 
Se (mg/kg) 0.62  0.08 0.60  0.05 0.56  0.07 0.61  0.06 
Mo (mg/kg) 7.6  0.4 8.1  0.7 7.5  0.9 7.5  0.4 
Cd (mg/kg) 0.20  0.01 4.30  0.3 32.1  1.5 149  10 
Pb (mg/kg) 0.18  0.01 0.19  0.01 0.20  0.01 0.21  0.01 
 
 
Values are mean  SD of five determinations 
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Fig.3 
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Fig.4 
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